Adam Beck, M.D., Holt A. McDowell Jr., M.D., Endowed Chair of Vascular Surgery at UAB and UAB Vascular Surgery Integrated Resident, Angela Sickels, M.D., aimed to determine what part of the population ...
The global aortic endograft industry was valued at around USD 3,255.5 million in 2023 and is anticipated to exhibit a CAGR of 4.9% over the forecast period. Accordingly, total market revenue is set to ...
NEWARK, Del, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The aortic endograft market is expected to grow at a compound annual growth rate (CAGR) of 4.9% during the forecast period, from an estimated valuation ...
Abdominal aortic endoleaks after endovascular aneurysm repair might be position-dependent, therefore undetectable using supine imaging. We aimed to determine the feasibility and benefit of using a low ...
This retrospective study analyzed prospectively collected data of patients treated with elective inner-branched endovascular aneurysm repair (iBEVAR) using an Artivion ® E-xtra custom-made endograft.
Transcatheter pulmonary valve replacement (TPVR) in patients with a congenital or acquired abnormality resulting in enlarged right ventricular outflow tract (RVOT) is challenging and may preclude ...
Background and objective: The G-Branch endograft is a novel multibranched “off-the-shelf” device used to repair thoracoabdominal aortic aneurysms (TAAAs). This report describes the hemodynamic and ...
IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, has ...
April 27, 2023—Endologix LLC announced the online publication of final 5-year results of the LEOPARD randomized controlled trial comparing outcomes of endovascular aneurysm repair using the Endologix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results